Early tolerance to the hypophagic effect of the cannabinoid receptor antagonist SR141716 does not impede blockade of an orexigenic stimulus

European Journal of Pharmacology

Volumn 542, Issue 1-3, 2006, Pages 116-120

  Rigamonti, Antonello E ^a   Giordani, Claudio ^a   Bonomo, Sara M ^a   Cella, Silvano G ^a   Müller, Eugenio E ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Body weight; Food intake; Hexarelin; SR141716; Tolerance

Indexed keywords

APPETITE STIMULANT; CANNABINOID RECEPTOR ANTAGONIST; ENDOCANNABINOID; GHRELIN; GROWTH HORMONE RELEASING FACTOR; HEXARELIN; RIMONABANT;

ANIMAL EXPERIMENT; APPETITE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG TOLERANCE; FOOD INTAKE; HYPOPHAGIA; MALE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; RAT; STIMULATION; WEIGHT REDUCTION;

ANALYSIS OF VARIANCE; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; EATING; INJECTIONS, INTRAPERITONEAL; MALE; OLIGOPEPTIDES; PIPERIDINES; PYRAZOLES; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CANNABINOID; TIME FACTORS;

EID: 33745977406     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.05.028     Document Type: Article

References (26)

1. Arvat E., Broglio F., Amaretti G., Benso A., Giordano R., Deghenghi R., and Ghigo E. Ghrelin and synthetic GH secretagogues. Best Pract. Res. Clin. Endocrinol. Metab. 16 (2002) 505-517
2. Bizzarri C., Rigamonti A.E., Giannone G., Berardinelli R., Cella S.G., Cappa M., and Muller E.E. Maintenance of a normal meal-induced decrease in plasma ghrelin levels in children with Prader-Willi syndrome. Horm. Metab. Res. 36 (2004) 164-169
3. Cani P.D., Montoya M.L., Neyrinck A.M., Delzenne N.M., and Lambert D.M. Potential modulation of plasma ghrelin and glucagon-like peptide-1 by anorexigenic cannabinoid compounds, SR141716A (rimonabant) and oleoylethanolamide. Br. J. Nutr. 92 (2004) 757-761
4. Carlini V.P., Varas M.M., Cragnolini A.B., Schioth H.B., Scimonelli T.N., and de Barioglio S.R. Differential role of the hippocampus, amygdala, and dorsal raphe nucleus in regulating feeding, memory, and anxiety-like behavioral responses to ghrelin. Biochem. Biophys. Res. Commun. 313 (2004) 635-641
5. Colombo G., Agabio R., Diaz G., Lobina C., Reali R., and Gessa G.L. Appetite suppression and weight loss after the cannabinoid antagonist SR 141716. Life Sci. 63 (1998) 113-117
6. Cota D., Marsicano G., Lutz B., Vicennati V., Stalla G.K., Pasquali R., and Pagotto U. Endogenous cannabinoid system as a modulator of food intake. Int. J. Obes. Relat. Metab. Disord. 27 (2003) 289-301
7. DelParigi A., Tschop M., Heiman M.L., Salbe A.D., Vozarova B., Sell S.M., Bunt J.C., and Tataranni P.A. High circulating ghrelin: a potential cause for hyperphagia and obesity in Prader-Willi syndrome. J. Clin. Endocrinol. Metab. 87 (2002) 5461-5464
8. Di S., Malcher-Lopes R., Halmos K.C., and Tasker J.G. Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. J. Neurosci. 23 (2003) 4850-4857
9. Fride E., Bregman T., and Kirkham T.C. Endocannabinoids and food intake: newborn suckling and appetite regulation in adulthood. Exp. Biol. Med. 230 (2005) 225-234
10. Ghigo E., Broglio F., Arvat E., Maccario M., Papotti M., and Muccioli G. Ghrelin: more than a natural GH secretagogue and/or an orexigenic factor. Clin. Endocrinol. 62 (2005) 1-17
11. Harrold J.A., and Williams G. The cannabinoid system: a role in both the homeostatic and hedonic control of eating?. Br. J. Nutr. 90 (2003) 729-734
12. Kirkham T.C., Williams C.M., Fezza F., and Di Marzo V. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br. J. Pharmacol. 136 (2002) 550-557
13. Kojima M., and Kangawa K. Ghrelin: structure and function. Physiol. Rev. 85 (2005) 495-522
14. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., and Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 (1999) 656-660
15. Monteleone P., Martiadis V., Rigamonti A.E., Fabrazzo M., Giordani C., Muller E.E., and Maj M. Investigation of peptide YY and ghrelin responses to a test meal in bulimia nervosa. Biol. Psychiatry 57 (2005) 926-931
16. Naleid A.M., Grace M.K., Cummings D.E., and Levine A.S. Ghrelin induces feeding in the mesolimbic reward pathway between the ventral tegmental area and the nucleus accumbens. Peptides 26 (2005) 2274-2279
17. Papotti M., Ghe C., Cassoni P., Catapano F., Deghenghi R., Ghigo E., and Muccioli G. Growth hormone secretagogue binding sites in peripheral human tissues. J. Clin. Endocrinol. Metab. 85 (2000) 3803-3807
18. Saper C.B., Chou T.C., and Elmquist J.K. The need to feed: homeostatic and hedonic control of eating. Neuron 36 (2002) 199-211
19. Tucci S.A., Rogers E.K., Korbonits M., and Kirkham T.C. The cannabinoid CB1 receptor antagonist SR141716 blocks the orexigenic effects of intrahypothalamic ghrelin. Br. J. Pharmacol. 143 (2004) 520-523
20. Van der Lely A.J., Tschop M., Heiman M.L., and Ghigo E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr. Rev. 25 (2004) 426-457
21. Vickers S.P., Webster L.J., Wyatt A., Dourish C.T., and Kennett G.A. Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats. Psychopharmacology 167 (2003) 103-111
22. Wenger T., Ledent C., and Tramu G. The endogenous cannabinoid, anandamide, activates the hypothalamo-pituitary-adrenal axis in CB1 cannabinoid receptor knockout mice. Neuroendocrinology 78 (2003) 294-300
23. Williams C.M., and Kirkham T.C. Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors. Psychopharmacology 143 (1999) 315-317
24. Williams C.M., Rogers P.J., and Kirkham T.C. Hyperphagia in pre-fed rats following oral delta9-THC. Physiol. Behav. 65 (1998) 343-346
25. Wren A.M., Seal L.J., Cohen M.A., Brynes A.E., Frost G.S., Murphy K.G., Dhillo W.S., Ghatei M.A., and Bloom S.R. Ghrelin enhances appetite and increases food intake in humans. J. Clin. Endocrinol. Metab. 86 (2001) 5992-5995
26. Wren A.M., Small C.J., Abbott C.R., Dhillo W.S., Seal L.J., Cohen M.A., Batterham R.L., Taheri S., Stanley S.A., Ghatei M.A., and Bloom S.R. Ghrelin causes hyperphagia and obesity in rats. Diabetes 50 (2001) 2540-2547